Immunity to Pasteurella multocida in protein-deficient chickens

Studies were conducted to determine the effects of dietary protein restriction on the humoral immunity (HI) and cell-mediated immunity (CMI) of chickens. New Hampshire chickens were separated into two dietary treatment groups: basal, containing 3,200 kcal/kg and 21% protein; or protein restricted (PR), containing 3,200 kcal/kg and 7% protein. In studies involving HI, half of the birds in each dietary treatment were vaccinated against fowl cholera at 4 and 8 wk of age. Blood samples were collected weekly beginning at 4 wk of age. Overall, unvaccinated birds had lower titers than vaccinated birds and PR groups generally showed lower titers than basal groups. All birds were challenged by palatine cleft inoculation of live, virulent Strain X-73 of Pasteurella multocida. The vaccinated PR group survived live challenge as well as the vaccinated basal group, but all unvaccinated birds died as a result of the challenge, regardless of antibody titer. In studies involving CMI, half of the birds in each dietary treatment were vaccinated at 5 wk of age. At 2 to 3 wk postvaccination, representative birds from each treatment were bled for total and differential blood counts. Also, birds were sacrificed and spleen cells collected. Cells were cultured in Roswell Park Memorial Institute (RPMI) medium with phytohemagglutinin-M (PHA-M), sonicated P. multocida (X-73), or RPMI only.(ABSTRACT TRUNCATED AT 250 WORDS)

Production of mouse monoclonal antibodies to Pasteurella multocida type A and the immunological properties of a protective anti-lipopolysaccharide antibody

Eight monoclonal antibodies (MAbs) were produced from mice immunised with whole cells of heat-killed Pasteurella multocida type A which had been cultured under iron-restricted conditions. The MAbs were selected by an enzyme-linked immunosorbent assay (ELISA) in which the antigen consisted of whole bacteria of the immunising strain. Their reactivity was investigated further by immunoblotting, indirect haemagglutination, a complement-mediated bactericidal assay and passive protection of mice. One of the eight MAbs was shown by immunoblotting to react with lipopolysaccharide (LPS), was bactericidal, and completely protected mice against homologous challenge with 10 LD50 of live bacteria. This MAb was selected for further study. Its reaction with LPS of 17 type-A strains and of single strains of types B, D and E was investigated by immunoblotting. Strains that reacted with the anti-LPS MAb in immunoblots were susceptible to its bactericidal activity and gave high ELISA absorbances. Those that did not react were not susceptible to its bactericidal activity and gave low ELISA readings. The relation between bactericidal activity and ELISA absorbance was highly significant (p less than 0.001). Five of the strongly reacting heterologous strains and one non-reacting strain were selected as challenge organisms in a passive protection experiment: only the mice receiving the reacting strains were protected.

The susceptibility of in vivo-grown Pasteurella haemolytica to ovine defence mechanisms in vitro

Pasteurella haemolytica organisms grown in vivo were examined for their susceptibility to ovine immune mechanisms in vitro. Compared with in vitro grown organisms they were less susceptible to opsonophagocytosis and, in contrast, susceptible to complement-dependent killing in the absence of exogenous antibody. These differences were not associated with phenotypic changes in the surface of the bacterial cell. However, overproduction and de novo synthesis of proteins was observed in in vivo grown organisms. Also, bound host-immunoglobulin was observed on in vivo grown organisms and a role for this in modifying the interaction with immune mechanisms is discussed.

[Further development of P. multocida vaccines for swine]

149 strains with antigen fractions of both A and D type could be found out of 446 P. multocida field strains of porcine origin. Most of them are producing the dermonecrotizing toxin. These A/D strains proved to be virulent in mice and piglets as well. In mice, the vaccination with one of the most virulent and immunogenic A/D strains, inactivated and A1(OH)3 adsorbed caused an immunity against challenge infections with P. multocida of types A, D and A/D. This effect could be confirmed on SPF piglets.

[Immunoprophylaxis against an acute P. multocida type D infection in Cairina moschata]

An acute P. multocida infection led to severe losses in a big Cairina moschata fattening farm. All isolated strains belong to serogroup D. After testing the virulence and immunogenic properties of the isolated strains in NMRI mice, we used an highly virulent and immunogenic strain for developing an inactivated vaccine (formaline inactivated, Al (OH)3 adsorbed, with a content of 3 x 10(9) bacteria/ml). Two sc. immunizations of Cairina at an age of 10 and 24 days resulted in immunity. All immunized animals survived the challenge infection. The immunity was stable till the 8th week after the 2nd immunization, later the intensity of the immunity decreased. A threefold immunization procedure in the Cairina farm was very successful.

Resistance to host immune defense mechanisms afforded by capsular material of Pasteurella haemolytica, serotype 1

Selected serum-mediated host immune defense mechanisms against Pasteurella haemolytica were studied using encapsulated and decapsulated organisms. When the capsular material was removed from P. haemolytica, it became more susceptible to serum agglutination, complement-mediated serum killing, and phagocytosis by polymorphonuclear leukocytes. When encapsulated organisms were used, phagocytosis was enhanced by antibodies to capsular material produced by vaccination of calves with any of three P. haemolytica vaccines. The serum bactericidal activity, however, was not facilitated by increased levels of anticapsular antibody in vaccinated cattle. By contrast, when decapsulated organisms were used, vaccination enhanced both the bactericidal and opsonizing capacities of sera from the calves. These studies indicate that capsular material should be considered a principal virulence factor for P. haemolytica.

Increased susceptibility to Pasteurella haemolytica in lambs infected with bovine respiratory syncytial virus

Groups of conventionally reared, 6- to 8-week-old lambs were inoculated intranasally and intratracheally with either bovine respiratory syncytial virus (BRSV) or BRSV followed by Pasteurella haemolytica 6 days later or with P. haemolytica alone. Lambs infected with P. haemolytica 6 days after experimental infection with BRSV had significantly higher disease scores, greater magnitudes of fever, and higher mortality rates than those infected with BRSV alone or with P. haemolytica alone (P less than 0.05). Mononuclear cells in the peripheral blood and lung lavage obtained from the BRSV-infected lambs were more susceptible to P. haemolytica cytotoxin than those obtained from control lambs (P less than 0.05). P. haemolytica was isolated in significantly greater numbers from lambs infected with BRSV and P. haemolytica than from those infected with P. haemolytica alone (P less than 0.05).

Colonisation by Pasteurella multocida in atrophic rhinitis of pigs and immunity to the osteolytic toxin

Gnotobiotic pig antisera to purified toxoid from a capsule type A or D strain of Pasteurella multocida contained large quantities of antitoxin but comparatively little antibody to a crude lysate of P. multocida. These sera given intraperitoneally to further pigs were almost completely protective against turbinate atrophy after intranasal inoculation of dilute acetic acid and infection with type D toxigenic P. multocida. In contrast, antisera to a crude lysate or bacterin of toxigenic P. multocida which contained large titres of antibody to P. multocida lysate, but no detectable antitoxin, were not protective. Colonisation by toxigenic P. multocida was significantly reduced in protected pigs and was similar to colonisation by nontoxigenic P. multocida in pigs untreated or treated with dilute acetic acid. These results indicated (1) that antitoxin was protective and cross protective between toxins from different capsule types; and (2) that the toxin was the main colonisation factor produced by toxigenic bacteria in the acetic acid model of infection and that immunity to it did not eliminate infection.

Serum resistance as an indicator of virulence of Pasteurella multocida for turkeys

Wildlife isolates of Pasteurella multocida, whose virulence for turkeys had previously been determined by intravenous inoculation, were characterized regarding their ability to survive incubation in fresh non-immune turkey serum. The relative virulence of the isolates was significantly associated with their ability to resist the bactericidal power of the serum as determined by standard plate counts following incubation. Organisms with a high survival value were more virulent; those with a low survival value were less virulent. A statistical model was specified and was successfully used to predict relative virulence of the P. multocida isolates. This method of assaying serum resistance was rapid, repeatable, and practical and could be performed with minimal laboratory equipment. Also studied was the serum resistance of seven serotype 3, 4 isolates obtained from the lungs of M9-vaccinated turkeys from seven flocks experiencing increased mortality due to fowl cholera. These isolates were shown to be identical to the M9 vaccine by restriction endonuclease analysis of chromosomal DNA. Six of the seven isolates had higher serum survival values than the original M9 vaccine.

Comparison of six different regimens for the control of atrophic rhinitis in swine

Effectiveness of six different programs of atrophic rhinitis (AR) control was evaluated under field conditions. Efficacy of treatments was recognized on the basis of--comparative evaluation of the average daily gain (ADG), morphometric examination of turbinate bones and computer conchal morphometry (TPR). Usefulness of the evaluated regimes differed significantly. TPR appeared to be the most objective method for AR evaluation. Correlation between severity of turbinate atrophy and ADG was only partial.

Protective effect of inactivated Pasteurella haemolytica bacterin challenged in bovine herpesvirus-1 experimentally infected calves

Formalin-inactivated and sonicated Pasteurella haemolytica bacterins were prepared from 1 h cultures of bacterial pellets in RPMI-1640 medium containing 7% fetal calf serum. The bacterial pellets were obtained from logarithmic phase growth of the organism by centrifugation. The protective effect of the vaccine was evaluated in 43 specific-pathogen-free Hereford crossbred calves and yearlings in three experiments. Cattle were either single vaccinated or boosted via three routes; intratracheally (i.t.), intranasally (i.n.) or intramuscularly (i.m.), using low or high doses. The two low-dose groups were also given supernatant by the same routes and volume as the bacterin. Cattle were challenged by P. haemolytica in aerosol at 24 or 39 days after last vaccination. To enhance the susceptibility of the cattle to this challenge, the cattle were exposed to bovine herpesvirus-1 aerosol 4 days before the bacterial challenge. The extent of pneumonia was significantly less in three groups of cattle (i.n.-i.n.,i.m.-i.n.,i.m.-i.m.) boosted with high dose of the bacterin than in the controls. Protection was observed when challenge isolates were heterologous or homologous to the isolates used to prepare the bacterins. It was also observed that the level of complement fixing antibody or anticytotoxin activity to P. haemolytica did not correlate with the degree of protection.

Persistence of the carrier status in haemorrhagic septicaemia (Pasteurella multocida serotype 6:B infection) in buffaloes

Fifty-seven young buffaloes were experimentally infected or naturally exposed to haemorrhagic septicaemia (HS). Of these animals 32 became immune carriers. They were observed in groups for periods up to 360 days to monitor the appearance of pasteurellae in the nasopharynx and antibody status. In most animals pasteurellae appeared in the nasopharynx for a short period initially and disappeared. The organism reappeared intermittently and the longest observed period of reappearance was 215 days after exposure. All animals showed rising antibody titres with a peak lasting for 150 to 180 days and declining thereafter. Pasteurellae persisted in the tonsils and were isolated from 20 out of 27 carriers after slaughter. The longest period when isolation was made after slaughter was 229 days. The organism lodged in the tonsils was unaffected by antibacterial therapy using drugs to which the organism displayed in vitro sensitivity. It is concluded that in HS, carrier animals exist in an active as well as a latent state, the former appearing for short intermittent periods between long latent periods, when pasteurellae continue to remain in the tonsils which constitute a long-term reservoir.

Bactericidal activity in the sera of mice vaccinated with Pasteurella multocida type A

The susceptibility of Pasteurella multocida to killing by serum and the ability of protective vaccines to stimulate this mechanism of immunity in mice were investigated. P. multocida type of bovine origin was used to prepare a vaccine incorporating heat killed organisms and for homologous infection of mice. Bactericidal capacity and ELISA antibody titres were determined for individual mouse sera. Protection was clearly associated with bactericidal antibodies raised by vaccination. The bactericidal assay may be useful as a rapid, simple screening test of vaccinated mice for functional protective antibody levels.

Comparison of enzyme-linked immunosorbent assay with dot immunobinding assay for detection of antibodies against Pasteurella multocida in turkeys

A dot immunobinding assay (DIA) was developed to detect antibodies against Pasteurella multocida in turkey serum. Five coating antigens, namely, whole-cell (WC) antigen, sonicated cell lysate (SCL), crude capsular extract (CE), formalin extract (FE), and heat-stable antigen (HSA), were compared by enzyme-linked immunosorbent assay (ELISA) and DIA using reference antisera against P. multocida organisms. WC and SCL antigens showed higher sensitivity, whereas FE and HSA antigens were more specific coating antigens in both assays. The specificity of DIA was greater than ELISA by comparing the P/N ratios of HSA against serum prepared from heterologous serotype of P. multocida. The DIA had also several distinct advantages over the ELISA, which included reduction of the manipulation time and more uniform binding of coating antigens onto the nitrocellulose membranes compared with binding of coating antigens to microtiter plates for ELISA.

A group level analysis of the associations between antibodies to seven putative pathogens and respiratory disease and weight gain in Ontario feedlot calves

The associations, at the group level, between serological titer to Pasteurella haemolytica surface antigens (Ph), Pasteurella haemolytica cytotoxin (Ph-cytox), infectious bovine rhinotracheitis virus (IBRV), bovine virus diarrhea virus (BVDV), parainfluenza-3 virus (PIV3), respiratory syncytial virus (RSV), Mycoplasma dispar (Md), M. bovis (Mb), and respiratory disease treatment rates, relapse rates, and 28 day weight gains were investigated in 14 groups of calves entering two feedlots during years 1983-1985, in Ontario. Based on least squares regression analyses, seroconversion rates to Mb and BVDV were predictive of increased respiratory disease rates, and seroconversion rates to Ph, Ph-cytox, Md and PIV3 were predictive of decreased weight gains. The R2 for predicting weight gains was much higher than for morbidity rates (0.75 vs 0.47 respectively). Titer data were not predictive of relapse rates. Group level analyses were performed because calves are managed as groups (e.g. pens) in commercial feedlots. Only BVDV seroconversion rates were related to increased risk of respiratory disease at both the individual and group levels of organization. Mycoplasma may be important factors in causing respiratory disease, and their relationship to potentiating the effects of other respiratory pathogens needs further investigation.

Specificity of bovine serum antibody to capsular carbohydrate antigens from Pasteurella haemolytica

A more complete understanding of the bovine immune response to antigens of Pasteurella haemolytica biotype A, serotype 1, will improve control of bovine respiratory disease (BRD). Sera were obtained from blood samples of calves as they transited the market system of eastern Tennessee and were transported to a feedlot in Texas. The clinical histories and performance data were recorded and compared with serologic findings. The calves underwent a natural challenge of BRD. Serologic and bacteriologic evaluation indicated that P. haemolytica A1 was a significant component of the challenge. Serum antibody titers against P. haemolytica A1 capsular antigens (in enzyme-linked immunosorbent assay and hemolysin-in-gel test) increased by day 15 and continued at high levels through day 56. The animals that remained free of BRD had higher initial serum antibody concentrations than those that succumbed to BRD. The specificity of the immunoglobulin G subclass 1 (IgG1) anticapsular antibody to P. haemolytica A1 increased from day 8 to day 29 as evidenced by a decrease in P. haemolytica A2 absorption inhibition from 60% (day 8) to 15% (day 29). However, IgA, IgG2, and IgM were more serotype specific on both days 8 and 29. There were no significant changes in anti-P. haemolytica A2 antibody titers. Both in vitro complement-dependent bacteriolysis and C3 deposition on the surface of the bacteria increased significantly (P less than 0.01) in a serotype-specific fashion from day 8 to day 29. These calves showed a humoral immune response to capsular polysaccharide antigens of P. haemolytica A1. Such a response may be an important component of immunity to BRD.

Immune defence mechanism against blood-borne Pasteurella multocida in turkeys

Humoral and cellular immune defence factors involved in controlling blood-borne Pasteurella multocida were investigated in turkeys by the passive transfer of immune serum or by the treatment with macrophage-activating agents. The treated and untreated birds were intravenously inoculated with a virulent strain of P multocida, and the viable bacteria in the blood, liver and spleen were counted. In untreated birds, the bacteria were rapidly removed from the blood, and the majority were recovered from the liver and spleen 120 minutes after inoculation. Neither the transfer of immune serum nor the treatment with macrophage-activating agents significantly influenced the clearance rate of bacteria from the blood. The number of bacteria recovered from the liver 120 minutes after inoculation was slightly lower in the birds treated with macrophage-activating agents and significantly lower in those given immune serum than in the untreated birds. None of the treatments, however, significantly changed the number of bacteria recovered from the spleen 120 minutes after inoculation. The results suggest that the phagocytes in the liver, but not in the spleen, play a crucial role in the intravascular defence against P multocida in the presence of specific antibodies.

Naturally acquired Pasteurella multocida infection in rabbits: immunological aspects

Natural infection with P. multocida in New Zealand White rabbits was followed in 2 to 3 weeks by development of immunoglobulin (Ig)M and IgG serum antibodies. The IgM response peaked and returned to lower levels within several weeks after infection, whereas the IgG response progressively increased and remained elevated.

Outer membrane proteins of bovine strains of Pasteurella multocida type A and their doubtful role as protective antigens

Outer membranes were prepared by the Sarkosyl method from 30 strains of Pasteurella multocida and the closely related Taxon 13, which had been isolated from cattle. The patterns of the outer membrane proteins (OMPs) on SDS-PAGE were generally similar to one another, though the four major proteins (a-d) varied somewhat in molecular mass; these patterns allowed the strains to be arranged into 12 groups. Taxon 13 strains and typical P. multocida strains were indistinguishable, both types being found within the same group. Mice were vaccinated with heat-killed bacteria of three strains and challenged with 10 LD50 of homologous and heterologous live bacteria, representing groups based on OMP patterns; the best protection was afforded by strain W674, which protected against nine of the 17 challenge strains; but there was no correlation between protection and PAGE pattern. Pre-vaccination and pre-challenge sera were used in immunoblotting to probe OMPs from protective and non-protective strains. All three vaccines produced antibody to proteins a and d; these proteins appeared to be common to all strains, varying in molecular mass but not in overall antigenic expression. The antibody response to the other two major OMPs appeared to be PAGE-group specific. There was no correlation between protection and the antigen pattern seen by immunoblotting.

Comparisons of Pasteurella multocida lipopolysaccharides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis to determine relationship between group B and E hemorrhagic septicemia strains and serologically related group A strains

Lipopolysaccharides (LPSs) purified from 16 reference somatic serotypes of Pasteurella multocida were examined and compared by discontinuous sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Resolution of LPS patterns in a gel was optimum when sample wells were cast separately from the stacking gel and the running gel consisted of 15% T (total monomer) polyacrylamide and 4 M deionized urea. Band patterns of P. multocida LPSs in a gel differed from control Salmonella minnesota wild-type and core mutant LPSs. Although the band patterns and mobilities of LPSs from some P. multocida reference serotypes were similar, none were identical. Evidence for O antigens similar to those produced by enterobacteria was not observed. Proteinase K digestion of whole P. multocida cells resulted in LPS band patterns similar to those of purified LPS. The presence or absence of a capsule on a strain had no major influence on band patterns in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Comparisons of LPS patterns of group B and E hemorrhagic septicemia strains with those of serologically related group A strains of P. multocida indicated that they were similar. Typing antisera made with purified serotype 2 or 5 LPS reacted with electroblots of all these strains. However, the reactions did not distinguish strains as being serotype 2 or 5.

Positive and negative aspects of host immune response to Haemophilus, Actinobacillus and Pasteurella

Haemophilus somnus, Actinobacillus pleuropneumoniae and Pasteurella haemolytica are economically important bacteria with pathogenic characteristics that require us to look further than killed, whole cell bacterins for induction of a protective immune response. A strong immune response is not synonymous with protection and the extreme specificity of the immune response works to our disadvantage when broad protection is needed. Detection of animals that are susceptible or immune to infection is important for the purpose of diagnosis and epidemiological study. However serum antibody levels are rarely indicative of protection unless it is known that the antibody of a particular isotype must be directed against a specific epitope for protection to occur. Parenteral vaccination with killed, whole cells of H. somnus, A. pleuropneumoniae or P. haemolytica produces, respectively, adequate protection, partial protection and increased disease. The reasons for these differences and methods of improving protection, based on an understanding of virulence determinants, are discussed.

New diagnostic techniques: a review of the HAP group of bacteria

Pasteurella haemolytica, Pasteurella multocida, Haemophilus somnus, Haemophilus parasuis and Actinobacillus pleuropneumoniae cause considerable economic loss in the cattle and swine industries. The literature relating to diagnostic procedures for these infections is reviewed. Both conventional and newer techniques are appraised in relation to the identification and classification of isolates, and to serological testing.

Differentiation of field isolates of Pasteurella multocida serotype 3,4 from live vaccine strain by genotypic characterization

Fifty-five serotype 3,4 isolates of Pasteurella multocida, isolated from turkeys dead from fowl cholera, were characterized (fingerprinted) genotypically for comparison with the serotype 3,4 live fowl cholera vaccine principally used in turkeys in California. Twenty-three isolates were obtained from turkeys vaccinated with the M9 live vaccine, and 32 additional isolates were from turkeys not vaccinated for fowl cholera. Methods of characterization included restriction endonuclease analysis of chromosomal DNA and ribotyping, a technique for highlighting restriction site heterogeneity of highly conserved ribosomal RNA genes and associated sequences using a radiolabeled rRNA probe. Eight different genotypes or ribotypes were detected in these isolates by the above methods. Of 23 isolates from M9-vaccinated turkeys flocks, 19 were the same ribotype as M9. Thirty of 32 isolates recovered from unvaccinated turkeys were different ribotypes from M9. The remaining two isolates resembled M9 and were recovered from two different flocks placed in succession on a turkey farm where a flock placed previously had been vaccinated with M9, suggesting interflock transmission. Ribotyping and restriction endonuclease analysis appear to be useful tools to aid in the determination of the role that the live vaccine plays in fowl cholera epidemiology.

Interactions of Haemophilus-Actinobacillus-Pasteurella bacteria with phagocytic cells

The Haemophilus-Actinobacillus-Pasteurella (HAP) group of bacteria contains a number of important veterinary and human pathogens. Although each species has specific characteristics and host range, most share the general property of being resistant to cellular defense mechanisms. In some cases (e.g. Pasteurella multocida, Pasteurella haemolytica and Actinobacillus pleuropneumoniae) resistance results in part from the presence of an antiphagocytic capsule that protects the bacilli against ingestion by neutrophils and macrophages. In other instances the bacteria aggressively attack mononuclear and polymorphonuclear phagocytes. For example, P. haemolytica, A. pleuro-pneumoniae and Actinobacillus actinomycetemcomitans each produce a leukotoxin that functionally impairs, and ultimately kills, leukocytes from cattle, pigs and human beings, respectively. Components of Pasteurella multocida and Haemophilus somnus have also been reported to adversely affect leukocyte functions. Another important area of research that is just emerging concerns the ability of lipopolysaccharide and other components of HAP bacteria to stimulate or modulate macrophage release of inflammatory mediators such as interleukin-1. In this paper, we provide an overview of the interactions of HAP bacteria with phagocytes and identify some of the common strategies by which they evade cellular defenses.